In Russia, quotas for the import and production of a number of narcotic drugs and psychotropic substances have been sharply increased. The production volume of thebaine increased the most – 23 times. Quotas have also been increased for fentanyl, clobazam and modafinil.
The government has approved state quotas for narcotic drugs and psychotropic substances, within the limits of which their production, storage, import and export are carried out. The resolution was published on the legal information portal and came into force.
In August, the Ministry of Health proposed making such changes to the Government of the Russian Federation Resolution No. 2108 dated November 30, 2021, the Pharmaceutical Bulletin reported.
The production quotas for thebaine in Russia have been increased the most – by 23 times. The amount of opium alkaloid allowed for release in the country was increased from 67.1 kg to 1.6 tons. Quotas for the production or import of fentanyl (from 45 to 90 kg) and clobazam (from 20 to 60 kg) have also been increased. In addition, quotas for the import of modafinil not registered in Russia have increased (from 17 to 100 kg).
In Russia, thebaine, fentanyl and clobazam are produced by the Moscow Endocrine Plant. Unlike the last two, thebaine is part of the combined narcotic analgesic Omnopon and is not marketed separately. According to Roszdravnadzor, since 2020, only seven series of the drug have been brought to market: one in 2020 and two series from 2021 to 2023 annually.
Clobazam is also imported by Sanofi. It is part of the tranquilizer “Frisium”, used to treat increased anxiety, as well as epilepsy.